1. Home
  2. VS vs PHIO Comparison

VS vs PHIO Comparison

Compare VS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • PHIO
  • Stock Information
  • Founded
  • VS 2013
  • PHIO 2011
  • Country
  • VS United States
  • PHIO United States
  • Employees
  • VS N/A
  • PHIO N/A
  • Industry
  • VS EDP Services
  • PHIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • PHIO Health Care
  • Exchange
  • VS Nasdaq
  • PHIO Nasdaq
  • Market Cap
  • VS 10.1M
  • PHIO 8.6M
  • IPO Year
  • VS N/A
  • PHIO N/A
  • Fundamental
  • Price
  • VS $2.21
  • PHIO $2.16
  • Analyst Decision
  • VS Hold
  • PHIO Strong Buy
  • Analyst Count
  • VS 1
  • PHIO 2
  • Target Price
  • VS $2.00
  • PHIO $9.00
  • AVG Volume (30 Days)
  • VS 58.7K
  • PHIO 703.0K
  • Earning Date
  • VS 08-13-2025
  • PHIO 08-13-2025
  • Dividend Yield
  • VS N/A
  • PHIO N/A
  • EPS Growth
  • VS N/A
  • PHIO N/A
  • EPS
  • VS N/A
  • PHIO N/A
  • Revenue
  • VS $230,132.00
  • PHIO N/A
  • Revenue This Year
  • VS $3,459.21
  • PHIO N/A
  • Revenue Next Year
  • VS N/A
  • PHIO N/A
  • P/E Ratio
  • VS N/A
  • PHIO N/A
  • Revenue Growth
  • VS 64.71
  • PHIO N/A
  • 52 Week Low
  • VS $1.00
  • PHIO $0.97
  • 52 Week High
  • VS $9.59
  • PHIO $9.79
  • Technical
  • Relative Strength Index (RSI)
  • VS 50.63
  • PHIO 50.19
  • Support Level
  • VS $1.92
  • PHIO $2.11
  • Resistance Level
  • VS $2.75
  • PHIO $2.30
  • Average True Range (ATR)
  • VS 0.22
  • PHIO 0.21
  • MACD
  • VS -0.02
  • PHIO -0.04
  • Stochastic Oscillator
  • VS 34.99
  • PHIO 9.65

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: